Abstract | BACKGROUND & AIMS: An association between hepatitis E virus (HEV) infection and cryoglobulinemia has been suggested. The aims of this study were to assess the prevalence of cryoglobulinemia during HEV infection in solid-organ-transplant (SOT) recipients, to describe its outcomes under ribavirin therapy and to evaluate its effects on kidney function and histology. METHODS: Between November 2005 and June 2016, 128 cases of HEV infection were diagnosed among SOT recipients followed in our institution. Cryoglobulinemia data obtained from 66 patients during acute-phase HEV and 51 patients during chronic-phase HEV were compared to a historical control group of 89 SOT recipients without HEV markers. Cryoglobulins were also monitored in a group of 43 patients treated by ribavirin. RESULTS: CONCLUSIONS: In conclusion, a relationship between HEV and cryoglobulin formation seems to exist. However, the clinical impact of cryoglobulinemia in SOT patients infected with HEV has to be confirmed.
|
Authors | Olivier Marion, Florence Abravanel, Arnaud Del Bello, Laure Esposito, Sebastien Lhomme, Bénédicte Puissant-Lubrano, Laurent Alric, Stanislas Faguer, Jacques Izopet, Nassim Kamar |
Journal | Liver international : official journal of the International Association for the Study of the Liver
(Liver Int)
Vol. 38
Issue 12
Pg. 2178-2189
(12 2018)
ISSN: 1478-3231 [Electronic] United States |
PMID | 29845733
(Publication Type: Journal Article)
|
Copyright | © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Chemical References |
- Antiviral Agents
- Ribavirin
|
Topics |
- Adult
- Antiviral Agents
(therapeutic use)
- Cryoglobulinemia
(virology)
- Female
- France
- Hepatitis E
(complications, diagnosis, drug therapy)
- Humans
- Immunocompromised Host
- Kidney
(physiopathology)
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Ribavirin
(therapeutic use)
- Transplant Recipients
|